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Objectives This study was designed to compare the accuracy of 64-row contrast computed tomography (CT), invasive cine-
ventriculography (CVG), 2-dimensional echocardiography (2D Echo), and 3-dimensional echocardiography (3D
Echo) for left ventricular (LV) function assessment with magnetic resonance imaging (MRI).
Background Cardiac function is an important determinant of therapy and is a major predictor for long-term survival in pa-
tients with coronary artery disease. A number of methods are available for assessment of function, but there are
limited data on the comparison between these multiple methods in the same patients.
Methods A total of 36 patients prospectively underwent 64-row CT, CVG, 2D Echo, 3D Echo, and MRI (as the reference
standard). Global and regional LV wall motion and ejection fraction (EF) were measured. In addition, assessment
of interobserver agreement was performed.
Results For the global EF, Bland-Altman analysis showed significantly higher agreement between CT and MRI (p 
0.005, 95% confidence interval: 14.2%) than for CVG (20.2%) and 3D Echo (21.2%). Only CVG (59.5 
13.9%, p  0.03) significantly overestimated EF in comparison with MRI (55.6  16.0%). CT showed signifi-
cantly better agreement for stroke volume than 2D Echo, 3D Echo, and CVG. In comparison with MRI, CVG—but
not CT—significantly overestimated the end-diastolic volume (p  0.001), whereas 2D Echo and 3D Echo signifi-
cantly underestimated the EDV (p  0.05). There was no significant difference in diagnostic accuracy (range:
76% to 88%) for regional LV function assessment between the 4 methods when compared with MRI. Interob-
server agreement for EF showed high intraclass correlation for 64-row CT, MRI, 2D Echo, and 3D Echo (intraclass
correlation coefficient 0.8), whereas agreement was lower for CVG (intraclass correlation coefficient  0.58).
Conclusions 64-row CT may be more accurate than CVG, 2D Echo, and 3D Echo in comparison with MRI as the reference
standard for assessment of global LV function. (J Am Coll Cardiol 2012;59:1897–907) © 2012 by the
American College of Cardiology Foundation
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LV Function Assessment Using MRI, CT, CVG, and Echo May 22, 2012:1897–907Left ventricular (LV) function is
an important factor in terms of
patient management, outcome,
and long-term survival of patients
with cardiac disease (1,2). Several
diagnostic methods are available to
evaluate LV function, among
which 2-dimensional echocardi-
ography (2D Echo) is the most
widely used because it offers fast,
relatively inexpensive, and non-
invasive functional analysis without
radiation exposure or contrast me-
dium administration. Nevertheless,
2D Echo has several limitations,
including operator dependence,
variable acoustic windows, and in-
adequate endocardial border dis-
crimination (3,4). Furthermore, it
depends on the use of geometric assumptions (5). Three-
dimensional echocardiography (3D Echo) overcomes these
limitations by capturing entire volumes, which is of great
importance in deformed ventricles (6–8). Another option is
biplane cineventriculography (CVG) as part of cardiac
catheterization, whose invasive nature has important draw-
backs. Additionally, being a projectional method, CVG is
limited by similar geometric assumptions as 2D Echo.
Magnetic resonance imaging (MRI) is considered the
method of choice for global and regional myocardial func-
tion assessment (9).
In recent multicenter studies, 64-row computed to-
mography (CT) was proven to be reliable and accurate in
noninvasively assessing the coronary arteries (10 –12).
Moreover, CT also enables assessment of LV function
Abbreviations
and Acronyms
2D Echo  2-dimensional
echocardiography
3D Echo  3-dimensional
echocardiography
CT  computed
tomography
CVG 
cineventriculography
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
LV  left ventricular
MRI  magnetic resonance
imaging
SV  stroke volume
Figure 1 Normal Left Ventricular Function in an 82-Year-Old Wo
(Top row) Diastole and (bottom row) systole studied by (A) magnetic resonance ima
(D) 3-dimensional echocardiography, (E) cineventriculography.(13–15). Although it has been shown that coronary CT
angiography has become more reliable with the increas-
ing detector rows to 64-row scanners (12,16), it remains
unclear if these scanners also allow improved LV function
assessment. We therefore performed an intraindividual
comparative effectiveness assessment of all 5 tests (64-
row CT, 2D Echo, 3D Echo, and CVG, with MRI as the
reference) for evaluation of global and regional LV
function (Fig. 1).
Methods
Study design. This prospective diagnostic performance
study was carried out as an ancillary single-center study of
the CorE 64 multicenter trial (11,17) to evaluate 64-row
CT, 2D Echo, 3D Echo, and CVG for the assessment of
global and regional LV function, using MRI as the refer-
ence standard. An intention-to-diagnose design was used;
no patients or segments were excluded because of poor
image quality, but instead were considered nondiagnostic.
The locations of the 25 criteria of the Standards for
Reporting of Diagnostic Accuracy studies statement (18) in
this report are summarized in Online Table 1. All patients
underwent all 5 tests within 24 h to minimize changes in
cardiac function. The study protocol was approved by the
institutional review board, and written informed consent
was obtained from all patients.
Study group. The study group consisted of consecutive
patients who had a clinical indication for conventional
coronary angiography and were referred to Charité Medical
School for coronary catheterization. Inclusion criteria for
this study were sinus rhythm and an age of at least 40 years
(17). Patients with a known allergy to iodinated contrast
agent, contraindication to beta-blockers or nitroglycerin,
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May 22, 2012:1897–907 LV Function Assessment Using MRI, CT, CVG, and Echowho were pregnant, who had renal insufficiency (creatinine
clearance of 60 ml/min or serum creatinine of more than
1.5 mg/dl), who had coronary bypass grafts, who had
undergone coronary intervention within 6 months before
study enrollment as pre-specified (17), or who had known
contraindications to MRI (e.g., pacemaker) were excluded.
In addition, women of childbearing age had a pregnancy test
before enrollment. Enrollment took place between August
8, 2006, and January 31, 2007 (excluding holidays and
weekends).
MRI acquisition protocol and data analysis. MRI was
performed on a 1.5-T scanner (Magnetom Avanto, Siemens
AG, Erlangen, Germany). For cardiac synchronization and
patient monitoring, an active 3-lead electrocardiography
system was used. Cine MRI scans were acquired in the 2-,
3-, and 4-chamber view and short-axis orientations during
end-expiratory breath-hold using a segmented fast steady-
state free precession sequence, as recently described (19).
Imaging parameters were repetition time: 2.8 ms, echo time:
1.2 ms, slice thickness: 8 mm, no interslice gap, voxel size:
1.7  1.3  8 mm3, acquisition window/cardiac phase: 34
s (24 segments per phase), slice resolution: 100%, and flip
ngle: 54° (20,21). Parallel imaging with a factor of 2 was
sed, and 2 slices along the short-axis orientations were
cquired during a single breath-hold covering the entire
eart from base to apex without gaps.
Analysis of global LV function was performed on a
ommercially available workstation (ARGUS version
A60c, Siemens) using Simpson’s rule for calculating end-
iastolic volume (EDV), end-systolic volume (ESV), stroke
olume (SV), ejection fraction (EF), and myocardial mass.
or this, epicardial and endocardial borders were marked on
ach slice, the luminal area then was multiplied by the slice
hickness, and the volumes of the slices finally were added.
asal slices with less than a semicircular muscular ring at
nd systole were disregarded, papillary muscles were as-
igned to the LV muscle (22), and the LV outflow tract was
ot included. End-systole and end-diastole then were de-
ected automatically by the software according to the small-
st and largest ventricular volume.
4-row CT acquisition protocol, image reconstruction,
nd data analysis. Images were acquired during a single
Patient CharacteristicsTable 1 Patient Characteristics
Age, yrs 62.2 11.2
Male 31 (86)
Hyperlipoproteinemia 23 (64)
Diabetes mellitus 7 (19)
Hypertension 24 (67)
Smokers 7 (19)
BMI 25 kg/m2 7 (19)
Known coronary artery disease 11 (31)
Previous myocardial infarction 6 (17)
Values are mean  SD or n (%).
BMI  body mass index.ubmaximum inspiratory breath-hold on a 64-row CT- Ccanner (Aquilion 64, Toshiba, Otawara, Japan) using 64 
.5-mm collimation. The examination was carried out using
tube voltage of 120 kV, a tube current of 240 to 400 mA
according to patient body weight and sex), pitch of 0.2 to
.225 (according to heart rate), and a gantry rotation time of
00 ms (17). The effective dose was estimated using
T-Expo (23). Parallel to the scan, an electrocardiogram
as recorded digitally to allow retrospective gating. If a
atient’s heart rate exceeded 70 beats/min, a beta-blocker
atenolol) was administered 1 h before the examination.
hen this approach did not result in adequate heart rate
owering, a short-lasting beta-blocker (esmolol) was admin-
stered intravenously immediately before the examination
n the scanning table. In addition, all patients also received
.2 mg nitroglycerin sublingually immediately before the
can, which was optimized for coronary CT angiography, to
ncrease coronary artery diameters (24). A total of 80 to 100
l, depending on the patient’s body weight, of a nonionic
ontrast agent (iopamidol 370, Bracco, Konstanz, Ger-
any) was injected into a cubical vein at a flow rate of 3.5
o 5 ml/s, followed by a saline chaser bolus of 40 ml at a flow
f 3 ml/s. The automatic bolus-tracking feature of the
canner was used to start image acquisition when a thresh-
ld of 180 HU in the descending aorta was reached (17).
From the raw data of each scan, axial image series with
.5-mm slice thickness and an increment of 0.5 mm were
econstructed by means of adaptive multisegment (multi-
ycle) reconstruction using data from up to 4 consecutive
eart beats for the same phase at 10 time points in 10%
ntervals of the cardiac cycles, as recently described (19).
hese 0.5-mm images were used to assess function with the
canner’s en suite software (Aquilion 64 version 3.00,
oshiba, Otawara, Japan). Short-axis slices of 8 mm width
ithout interslice gap were generated. The software’s semi-
utomatic endocardial and epicardial border detection tool
as used on each short-axis slice, adjusting them manually
f necessary, as described recently (25). Similar to MRI,
apillary muscles also were assigned to the LV muscle (22),
nd basal slices with less than a 180° circumferential LV
uscle ring during end-systole were disregarded as recom-
ended (26). The LV outflow tract was not included.
impson’s rule was used to calculate LV volumes. Subse-
uently, end-systolic and end-diastolic phases were detected
utomatically by the software according to the smallest and
argest ventricular volume, similar to MRI.
VG data acquisition and data analysis. All patients
nderwent biplane CVG using standard x-ray techniques
uring end-expiratory breath hold with a frame rate of 30/s
nd injecting 30-ml iodated contrast media at a flow rate of
0 to 12 ml/s using a 5- or 7-F pigtail catheter.
LV function was analyzed in 2 orthogonal planes (30°
ight anterior oblique and 60° left anterior oblique) using a
ommercially available workstation (Med Con, Tel Aviv,
srael). Ventricular borders were traced automatically by
order detection software that could be adjusted manually.
onsequently, absolute cardiac function values were calcu-
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LV Function Assessment Using MRI, CT, CVG, and Echo May 22, 2012:1897–907lated using the area-length method and metallic spheres for
calibration (27,28). For comparison of effective radiation dose
of catheterization (including angiography and CVG), we used
dose area product measurements with a conversion factor (0.2
mSv/cGy · cm), including only radiation associated with the
diagnostic coronary angiogram and CVG (29).
2D Echo and 3D Echo acquisition protocol and data
analysis. All patients underwent 2D Echo as well as 3D
Echo. 2D Echo was performed at a frame rate of 40 to 80
frames/s in the left lateral decubitus position to obtain
standard 2-, 3-, and 4-chamber as well as short-axis views
(GE Vingmed Vivid 7 Dimension, Horton, Norway; 2.5-
MHz transducer). Manual tracing of the endocardial bor-
ders at end systole and end diastole was performed, and the
modified biplane Simpson’s rule was used to calculate
end-systolic and end-diastolic volumes (30). After 2D
Echo, the machine’s 1.5- to 3.6-MHz 3V transducer (GE
Vingmed Vivid 7 dimension) was used to obtain 3D
pyramidal datasets (sector angle: 80°  82°) at a frame rate
f 39 frames/s during an end-expiratory breath hold lasting
p to 6 heart beats. All acquired real-time 3D datasets then
ere transferred to a dedicated workstation (TomTec 4D,
omTec Imaging Systems GmbH, München, Germany),
nd LV volumes were calculated semiautomatically (31).
ssessment of regional function and experience level of
he reader. For regional LV function assessment (Fig. 2),
e rated all 17 myocardial segments (32) using a 4-point
cale (1  normal, 2  hypokinesia, 3  akinesia, 4 
yskinesia). All assessments (both global and regional as-
essments) were performed by 2 readers who were blinded
o each other and to the results of the other tests. The
eaders had the following levels of experience: MRI, 3 and
years (E.Z., B.H.); 64-row CT, 4 and 8 years (J.G.,
Figure 2 Abnormal Regional Function in a 53-Year-Old Man
(Top row) Diastole and (bottom row) systole studied by (A) magnetic resonance ima
(D) 3-dimensional echocardiography, (E) cineventriculography. During systole, all tests
Note also the thinning of the septal wall (A to C) and the darkening of the subendoca.D.); echocardiography, 5 and 15 years (A.G., A.C.B.);
nd CVG, more than 20 years each (W.R., H.P.D.).
mage quality. Overall image quality was assessed on a
-point scale for all 5 tests: 1  nondiagnostic; 2  poor;
 average; 4  good; 5  very good.
tatistical analysis. All data are expressed as mean  SD
nless otherwise stated. According to the intention-to-
iagnose design of the study, no patient or segment was
xcluded because of poor image quality, but instead was
onsidered nondiagnostic. For intermethod analysis, the
esults of the most experienced reader of each method were
sed. LV cardiac function parameters of 64-row CT, CVG,
D Echo, and 3D Echo were compared with MRI as the
eference standard using Pearson’s correlation and limits of
greement (1.96  SD  95% confidence intervals) deter-
ined by Bland-Altman analysis (33). A paired Student t
est was used to test for any overestimation or underestima-
ion, and a 2-tailed F test was used to compare the size of
he limits of agreement of 64-row CT, CVG, 2D Echo, and
D Echo in reference to MRI in the Bland-Altman analy-
is. Furthermore, we used the methods described above to
ompare 64-row CT with MRI regarding myocardial mass.
In addition, for assessment of sensitivity, specificity, and
ositive and negative predictive value for abnormal regional
ardiac function (grades 2 to 4), the results of MRI served as
eference for evaluation of 64-row CT, CVG, 2D Echo, and
D Echo. We used a McNemar test to compare the
iagnostic performance for detection of regional wall mo-
ion abnormality on the per-patient and per-segment level
etween 64-row CT, CVG, 2D Echo, and 3D Echo.
ccuracy in differentiation of wall motion deficits on the
-point scale for CT, CVG, 2D Echo, and 3D Echo was
ompared with MRI as the reference standard using a paired
B) 64-row computed tomography, (C) 2-dimensional echocardiography,
hypokinesis (arrow) of the anteroseptal myocardial segment (segment 7).
order in this area (A, B), which are the result of prior ischemic damage.ging, (
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May 22, 2012:1897–907 LV Function Assessment Using MRI, CT, CVG, and EchoMcNemar test and Cohen’s kappa statistic on the per-
segment level. We used Bland-Altman analysis as well as
intraclass correlation analysis for global function assessment
and Cohen’s kappa for regional function assessment. Fur-
thermore, we used Friedman’s test to compare image
quality. Statistical analysis was conducted using SPSS soft-
ware version 12.0 (SPSS, Inc., Chicago, Illinois). A p value
0.05 was considered significant.
Results
During the enrollment period, 83 patients were eligible, of
whom 7 eligible patients were not in sinus rhythm, 3 and 4
had contraindications to iodinated contrast agents and
beta-blockers, respectively, 4 had coronary artery bypass
grafts or coronary interventions within 6 months before
study enrollment, and 2 had cardiac pacemakers. Another 6
patients were already recruited into other trials. Of the
remaining 57 eligible patients, 14 declined to participate
and 7 had to be excluded because of time constraints and
unavailability of at least 1 of the 5 tests during the 24 h
period. Thus, 36 patients (Table 1) with suspected (n  26)
r known (n  10) coronary disease successfully com-
leted the study and underwent the 5 diagnostic tests
ithin 24 h without any complications or intermediate
ardiac events.
For 64-row CT, on average 81.1  4.6 ml contrast agent
as administered intravenously, and the effective dose was
6.2 1.7 mSv (23). The average heart rate during CT was
8.7  8.7 beats/min, and the average length of the image
econstruction window was 179.0  14.8 ms. Thirteen
atients required intravenous beta-blockade (esmolol 245
45 mg) and 1 patient received an additional oral beta-
locker (50 mg atenolol). For diagnostic cardiac catheter-
zation, the total effective dose was 13.8 6.8 mSv and 86.5
1.2 ml (including 30 ml for CVG) of contrast agent used
both p  0.05 vs. CT).
Overall EF measured by MRI was 55.6  16.0% (range:
2.6% to 74.6%), and one third of the patients (12 of 36)
howed reduced EF (55%).
mage quality. Overall image quality was not significantly
ifferent (p  0.22 for all) between 64-row CT (3.0  0.8),
D Echo (3.2  0.9), 3D Echo (3.0  1.0), CVG (3.3 
.7), and MRI (3.6  0.9). None of the examinations was
eemed nondiagnostic by the respective readers.
V EF. There was no significant overestimation or under-
stimation by 64-row CT, 2D Echo, or 3D Echo in
omparison with MRI (Fig. 3A), but CVG significantly
verestimated EF (p  0.03, t test) (Table 2). Compared
ith the limits of agreement for 64-row CT versus MRI
14.2%), CVG (20.2%, p  0.02) and 3D Echo
21.2%, p  0.01) showed significantly larger variability.
urthermore, 64-row CT (Fig. 3B) showed an excellent
orrelation with MRI for EF (Table 2). There was good
orrelation for 2D Echo and 3D Echo as well as for CVG
Table 3). 64-row CT showed high intraclass correlation dith MRI, whereas CVG, 2D Echo, and 3D Echo showed
ood intraclass correlation (Online Table 2).
V EDV. For EDV, 64-row CT showed no significant
verestimation or underestimation (p 0.63), whereas both
D Echo (p  0.001) and 3D Echo (p  0.004) signifi-
antly underestimated this LV function parameter, and
VG (p  0.01) overestimated this LV function parameter
Table 2). Bland-Altman analysis demonstrated no signifi-
ant difference (p  0.05 for all) for the limits of agreement
or 2D Echo, 3D Echo, and CVG in comparison with
4-row CT (Fig. 3C). Again, there was good correlation
etween 64-row CT, 2D Echo, 3D Echo, and CVG
ompared with MRI (Table 3). There was high intraclass
orrelation for all 5 tests (Online Table 2).
V ESV. Similar to EDV, there was no significant over-
stimation or underestimation of ESV by 64-row CT (p 
.998), but 2D Echo (p 0.002) and 3D Echo (p 0.005)
ignificantly underestimated this LV function parameter,
nd CVG (p  0.001) overestimated this LV function
arameter (Table 2). Again, there were no significant
ifferences in the limits of agreement for any of the tests
Fig. 3D). Correlation analysis showed an excellent corre-
ation for 64-row CT, 2D Echo, 3D Echo, and CVG with
RI (Table 3). Again, there was high intraclass correlation
or all 5 tests (Online Table 2).
V SV. SV was overestimated significantly by both 64-row
T (p 0.02) and CVG (p 0.001) (Table 2). In contrast,
D Echo (p  0.01) significantly underestimated SV,
hereas 3D Echo showed no significant overestimation or
nderestimation of SV (Table 2). Bland-Altman analysis
evealed significantly larger limits of agreement (p  0.05
or all) for CVG as well as for 2D Echo and 3D Echo than
or 64-row CT (Fig. 3B). Correlation with MRI was
oderate for 64-row CT and was low for CVG, 2D Echo,
nd 3D Echo (Table 3). For SV, 64-row CT showed
oderate intraclass correlation, whereas CVG, 2D Echo,
nd 3D Echo showed only fair agreement (Online Table 2).
V myocardial mass. 64-row CT resulted in limits of
greement versus MRI of 42.0 g, with an excellent
orrelation between both tests (Table 3).
er-patient regional function. Using MRI as the refer-
nce standard, 22 of 36 patients were classified as having at
east 1 myocardial segment with a wall motion deficit (Fig. 2).
f these 22 patients, 7 patients also showed akinetic wall
egments, and 1 patient also showed dyskinetic wall
egments.
64-row CT showed a significantly higher sensitivity than
oth 2D Echo and 3D Echo (p  0.05 for both) (Table 4).
y contrast, 64-row CT showed a significantly lower
pecificity than both 2D Echo and 3D Echo (p  0.05 for
oth) (Table 4). See Online Tables 3 through 6 for
ross-tables for all tests versus MRI.
er-segment regional function. The reference standard,
RI, identified 154 segments with a wall motion deficit (a
core of at least 2: hypokinetic, n  102; akinetic, n  47;
yskinetic, n  5), and sensitivity of 64-row CT was
E1902 Greupner et al. JACC Vol. 59, No. 21, 2012
LV Function Assessment Using MRI, CT, CVG, and Echo May 22, 2012:1897–907significantly higher (p  0.001 for all) than that of CVG,
2D Echo, or 3D Echo (Table 5). The specificity of 2D
Echo (p  0.001), 3D Echo (p  0.001), and CVG (p 
0.009) was significantly better than that of 64-row CT,
Figure 3 Summary of the Bland-Altman Analysis of Intermethod
Comparison of the reference standard, magnetic resonance imaging (MRI), with
analysis, the mean of the difference of MRI and the index tests is given by the
64-row computed tomography (CT) did not overestimate or underestimate (A) e
(ESV) in comparison with MRI, but significantly overestimated (B) stroke volum
ventricular (LV) volumes (B to D), and both 2-dimensional echocardiography (2
estimation for (C) EDV and (D) ESV, whereas SV was underestimated significa
cant overestimation or underestimation compared with MRI. With regard to the
agreement (p  0.05) than 64-row CT for (A) EF and (B) SV, whereas for (C) E
agreement were larger for SV, but not for (A) EF, (C) EDV, and (D) ESV.   s
mation vs. MRI); #  significantly larger limits of agreement vs. 64-row CT.
Results of Global Left Ventricular Function Assessment With All 5Table 2 Results of Global Left Ventricular Function Assessmen
MRI 64-Row CT
EF (%) 55.6 16.0 56.9 14.7
EDV (ml) 131.1 59.4 137.3 50.0
ESV (ml) 65.6 61.9 65.7 51.7
SV (ml) 65.5 15.6 71.7 17.3*
MM (g) 152.5 57.8 136.2 51.9*
Values are mean  SD. *p  0.05, t test vs. MRI, indicating significant overestimation or undere
2D Echo 2-dimensional echocardiography; 3D Echo 3-dimensional echocardiography; CT compu
SV  end-systolic volume; MM  myocardial mass; MRI  magnetic resonance imaging; N/A  not avwhereas the diagnostic accuracy of the 4 tests was not
significantly different (Table 5). See Online Tables 7
through 10 for details on how all tests scored regional
function on the 4-point scale.
eement for Global Left Ventricular Function
esults of the 4 other tests using Bland-Altman analysis. In this Bland-Altman
circle with their limits of agreement (95% confidence intervals, 1.96 SD).
n fraction (EF), (C) end-diastolic volume (EDV), or (D) end-systolic volume
. In comparison, cineventriculography (CVG) significantly overestimated all left
o) and 3-dimensional echocardiography (3D Echo) showed a significant under-
ly by (B) 2D Echo. For (A) EF, both 3D Echo and 2D Echo showed no signifi-
of agreement, CVG and 3D Echo showed significantly larger limits of
d (D) ESV, there was no significant difference. Regarding 2D Echo, limits of
ant (p  0.05 overestimation vs. MRI);   significant (p  0.05 underesti-
ostic Tests in All 36 Patientsh All 5 Diagnostic Tests in All 36 Patients
2D Echo 3D Echo CVG
56.3 14.7 58.3 17.2 59.5 13.9*
105.3 53.4* 112.8 58.7* 191.0 59.5*
51.3 43.7* 52.6 48.4* 81.5 53.1*
54.0 23.0* 59.4 24.8 109.5 28.3*
N/A N/A N/A
n of this parameter by the respective test.Agr
the r
solid
jectio
e (SV)
D Ech
ntly on
limits
DV an
ignificDiagnt Wit
stimatio
ted tomography; CVG cineventriculography; EDV end-diastolic volume; EF ejection fraction;
ailable; SV  stroke volume.
reviatio
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May 22, 2012:1897–907 LV Function Assessment Using MRI, CT, CVG, and EchoInterobserver variability for global LV function. Regard-
ing EF, there was a significant difference between the 2
readers for MRI (p 0.001), but not for 64-row CT, CVG,
2D Echo, or 3D Echo. Furthermore MRI, 2D Echo, and
3D Echo also showed significant difference (p  0.05 for
all) between the 2 readers for ESV and EDV (Fig. 4). In
addition, for 2D Echo and 3D Echo, there was also a
significant difference (p 0.05 for both) for SV between the
2 readers.
The limits of agreement of CT for EF, EDV, ESV, and
SV showed no significant difference from those of MRI,
whereas 2D Echo showed significantly larger limits of
agreement. For EF, EDV, and ESV, 3D Echo showed
significantly larger limits of agreement, whereas CVG
showed larger limits of agreement only for SV. Intraclass
correlation regarding EF, EDV, and ESV was high for MRI,
64-row CT, 2D Echo, and 3D Echo (Online Table 11). CVG
intraclass correlation was moderate only for EF.
Interobserver variability for regional LV function. There
was no significant difference between the 2 readers on the
per-patient level for all 5 tests, although there was a trend
for significant difference with CT. CVG showed almost
perfect interrater agreement (kappa  0.94, p  0.99),
whereas MRI and 64-row CT both showed substantial
good interrater agreement (kappa  0.77, p  0.63, and
kappa 0.69, p 0.06, respectively). For 2D Echo and 3D
Echo, interrater agreement was moderate (kappa  0.46,
p  0.29, and kappa  0.31, p  0.18, respectively).
Correlation Analysis Results for Global Left Ventricular Function inTable 3 Correlation Analysis Results for Global Left Ventricular
64-Row CT vs. MRI 2D Echo vs. M
EF (%) R  0.89; p  0.001;
SEE  6.74; S  0.82;
I  10.3
R  0.79; p  0.0
SEE  9.11; S 
I  14.8
EDV (ml) R  0.90; p  0.001;
SEE  22.47; S  0.75;
I  38.6
R  0.84; p  0.0
SEE  29.11; S 
I  5.8
ESV (ml) R  0.96; p  0.001;
SEE  14.97; S  0.8;
I  13.1
R  0.94; p  0.0
SEE  14.80; S 
I  7.5
SV (ml) R  0.55; p  0.001;
SEE  14.70; S  0.61;
I  31.8
R  0.31; p  0.0
SEE  22.21; S 
I  23.9
MM (g) R 0.93 p  0.001;
SEE  19.42; S  0.83;
I  8.9
N/A
I  intercept; R  correlation coefficient; S  slope; SEE  standard error of estimate; other abb
Comparative Per-Patient Diagnostic Performance for Regional FuncTable 4 Comparative Per-Patient Diagnostic Performance for R
64-Row CT 2D
Sensitivity (%) 18/22 (82% [60–95]) 11/22 (5
Specificity (%) 5/14 (36% [13–65]) 13/14 (9
Positive predictive value 18/27 (67% [46–83]) 11/12 (9
Negative predictive value 5/9 (56% [21–86]) 13/24 (5
Diagnostic accuracy (%) 23/36 (64% [46–79]) 24/36 (6Values are n/N (% [95% confidence interval]). *p  0.05 versus 64-row CT. Further details of the cross t
Abbreviations as in Table 2.Discussion
This study is, to the best of our knowledge, the first
head-to-head comparison of 64-row CT, CVG, 2D Echo,
and 3D Echo with MRI for cardiac function assessment.
64-row CT was found to be superior in assessing global LV
parameters (EF, EDV, and ESV) compared with the 3
other diagnostic tests (CVG, 2D Echo, and 3D Echo) using
MRI as the reference standard. One of the reasons why
64-row CT was more accurate than the other tests may be
related to the fact that for CT and MRI, similar methods
for calculating global cardiac function are applied. CT and
the other methods showed similar diagnostic accuracy in
detecting regional wall motion deficits with MRI as the
reference standard. Additionally, our results also indicate
high interobserver reliability for both regional and global
LV function analysis using 64-row CT. All 5 diagnostic
tests were performed in 36 consecutive patients within an
individual period of 24 h.
In the recent past, 64-row CT has greatly advanced as a
noninvasive method for coronary angiography and also has
been found to allow accurate assessment of LV function
(13–15,34). For EF, the limits of agreement obtained with
64-row CT (14.2%) in comparison with MRI were
similar to those reported in previous studies using 64-row
CT by Guo et al. (35) (10.3%) and Puesken et al. (34)
(9.0%). For CVG, we also found a significant overesti-
mation of EDV and ESV, as previously reported by other
6 Patientstion in All 36 Patients
3D Echo vs. MRI CVG vs. MRI
R  0.79; p  0.001;
SEE  10.69; S  0.85;
I  9.5
R  0.77; p  0.001;
SEE  9.00; S  0.67;
I  24.4
R  0.82; p  0.001;
SEE  34.24; S  0.81;
I  6.8
R  0.84; p  0.001;
SEE  33.01; S  0.84;
I  81.2
R  0.92; p  0.001;
SEE  19.45; S  0.72;
I  5.4
R  0.92; p  0.001;
SEE  21.64; S  0.79;
I  29.9
R  0.27; p  0.12;
SEE  24.25; S  0.43;
I  31.6
R  0.44; p  0.04;
SEE  25.74; S  0.80;
I  57.0
N/A N/A
ns as in Table 2.
al Function
3D Echo CVG
–72])* 11/22 (50% [28–72])* 16/22 (73% [50–89])
–100])* 14/14 (100% [77–100])* 11/14 (79% [49–95])
–100]) 11/11 (100% [72–100])* 16/19 (84% [60–97])
–74]) 14/25 (56% [35–76]) 11/17 (65% [38–86])
–81]) 25/36 (69% [52–84]) 27/36 (75% [58–88])All 3Func
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LV Function Assessment Using MRI, CT, CVG, and Echo May 22, 2012:1897–907authors (14,36). This overestimation is the result of geo-
metric assumptions (28) and the angiographic magnification
error (37), which limits the comparability of CVG with the
other tests for EDV and ESV. By contrast, 3D Echo
significantly underestimated EDV and SV, which is in good
agreement with previous investigators (38–40) who primar-
Figure 4 Summary of the Bland-Altman Analysis of Interobserve
Comparison between 2 readers for all 5 tests using Bland-Altman analysis. In this
with their limits of agreement (95% confidence intervals,  1.96 SD). For 64-row C
showed significant difference for (A) EF, (C) EDV, and (D) ESV. 2D and 3D Echo s
agreement, 64-row CT showed smaller limits of agreement than 2D and 3D Echo f
cantly smaller limits of agreement for (B) SV, but significantly larger limits for (C)
ESV. *Significant (p  0.05) difference by the test between the 2 readers; #Signi
Abbreviations as in Figure 3.
Comparative Per-Segment Diagnostic Performance for Regional FunTable 5 Comparative Per-Segment Diagnostic Performance for
64-Row CT 2D
Sensitivity 126/154 (82% [75–88]) 88/154 (5
Specificity 392/458 (86% [82–89]) 451/458 (9
Positive predictive value 126/192 (66% [58–72]) 88/95 (9
Negative predictive value 392/420 (93% [91–96]) 451/517 (8
Diagnostic accuracy 518/612 (85% [82–87]) 539/612 (8
Youden index 0.67 0
Values are n/N (% [95% confidence interval]). *p 0.001 versus 64-row CT. †p 0.05 versus 64-ro
Abbreviations as in Table 2.ly attribute this underestimation to incomplete sampling of
he ventricle variability (38,40) and heart rate variability
39). Interestingly, 3D Echo did not perform better than
D Echo, which is in disagreement with the results reported
y Jenkins et al. (6). One reason may be the good overall LV
unction of the patients included in our study, whereas 3D
reement for Global Left Ventricular Function
ary, the mean of the difference between 2 readers is given by the solid circle
CVG, there was no significant difference between the 2 readers, whereas MRI
significant differences for (B) SV, (C) EDV, and (D) ESV. Regarding limits of
EF, (B) SV, and (C) EDV. When compared with CVG, 64-row CT showed signifi-
4-row CT showed significantly smaller limits of agreement than 2D Echo for (D)
larger limits of agreement between the 2 readers of the test versus MRI.
onal Function
3D Echo CVG
9–65])* 87/154 (56% [48–64])* 85/154 (55% [47–63])*
7–99])* 453/458 (99% [97–100])* 416/458 (91% [88–93])†
5–97])* 87/92 (95% [88–98])* 85/127 (67% [58–75])
4–90])† 453/520 (87% [84–90])† 416/485 (86% [82–89])*
5–91]) 540/612 (88% [85–91]) 501/612 (82% [79–85])
0.55 0.46
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May 22, 2012:1897–907 LV Function Assessment Using MRI, CT, CVG, and EchoEcho has been shown to improve assessment of global
cardiac function parameters in patients with large hearts,
cardiac aneurysms, or cardiomyopathy or after myocardial
infarction (8,41,42) because of the better geometrical rep-
resentation. In general, the accuracy of 64-row CT for
assessment of global LV function is in good agreement with
the results of a recent meta-analysis including 11 studies (15
cohorts) with 252 patients examined by 4- to 16-row CT in
comparison with MRI (43).
Our results are in good agreement with those of the study
of Annuar et al. (44) regarding the results of CT for regional
wall motion deficit detection with a sensitivity and specific-
ity of 82% and 86%, respectively. Dewey at al. (14) also
showed high sensitivity (88% and 75%, respectively) for the
detection of wall motion deficits using 16-row CT. Similar
to our results, Dewey et al. (14) also showed a significant
superiority of CT over CVG. Although multisegment
reconstruction was used to improve temporal resolution,
64-row CT is still far from the temporal resolution needed
for optimal identification of the end-systolic period (acqui-
sition window: 20 to 40 ms) (21) offered by echocardiogra-
phy (33 ms) or MRI (34 ms). The poorer temporal
resolution greatly limits the ability of CT to differentiate
regional wall motion deficits (Online Tables 7 to 10).
Regarding interobserver agreement, our results show a
high general intraclass correlation for 64-row CT, which
agrees well with results previously reported (45,46). Inter-
estingly, MRI showed significant interobserver variability
despite high intraclass correlation, which may be related to
the large degree of manual interaction and may be overcome
with additional consented training, as reported by Beer-
baum et al. (47). For 2D Echo, our results agree well with
the studies of Blondheim et al. (48) and Hoffman et al. (49),
which also showed good reliability (intraclass correlation
coefficient  0.78 and 0.79, respectively, vs. 0.86 for this
study) for EF. In contrast, for CVG, Hoffman et al. (49)
reported higher reliability regarding EF (intraclass correla-
tion coefficient  0.80 vs. 0.58 for this study). This again
ay be related to manual discrimination of cardiac bound-
ries as well as time points for end systole and end diastole.
tudy limitations. Nevertheless, our study also has relevant
imitations. One third of patients included (12 of 36) had
bnormal global LV cardiac function (EF55%). However,
n clinical practice, cardiac CT is used rarely in those
atients because its main field of application is coronary
ngiography in patients with low or moderate pretest
robabilities of coronary artery disease (50). As a result, the
umber of patients with poor cardiac function is even
maller in clinical practice. Nevertheless, 64-row CT also
howed accurate LV function assessment in patients with
educed cardiac function. Therefore, 64-row CT may be
sed in patients with contraindications to MRI (e.g., pace-
akers) or patients with poor acoustic windows in echocar-
iography, because it provides moderate to good accuracy
or global and regional LV function.In addition, 3D Echo required acquisition of datasets
uring up to 6 consecutive heartbeats, which may lead to
titching artifacts because of an unstable probe position or
ncorrect breath hold and limits the use of 3D Echo in
atients with atrial fibrillation. However, upcoming dual-
eat or single-beat techniques may help to overcome this
roblem (51,52).
Furthermore, modern scanners use special scanning tech-
iques such as step and shoot (53) or wide cone beam
etectors (54) to allow prospective triggering, which will
educe radiation exposure to 5 mSv in almost all patients.
n our study, we used retrospective triggering to allow
ardiac function assessment, resulting in approximately
6 mSv. Unfortunately, prospective triggering does not
llow functional assessment; however, prospective dose
odulation over the RR interval allows functional assess-
ent at the expense of only a slightly higher radiation
ose (55).
onclusions
4-row CT allows accurate and reliable evaluation of global
V function and seems to be superior to CVG, 2D Echo,
nd 3D Echo when MRI is used as the reference standard.
lso, the diagnostic accuracy of 64-row CT in detecting
all motion deficits seems to be similar to that of CVG, 2D
cho, and 3D Echo.
Reprints requests and correspondence: Dr. Marc Dewey, Insti-
tut für Radiologie, Charité Medical School, Charitéplatz 1, 10117
Berlin, Germany. E-mail: dewey@charite.de.
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